Cite
Features of the metabolic syndrome and subclinical atherosclerosis in patients with cerebrotendinous xanthomatosis: An augmented risk for premature cardiovascular disease.
MLA
Cohen, H., and S. Hassin-Baer. “Features of the Metabolic Syndrome and Subclinical Atherosclerosis in Patients with Cerebrotendinous Xanthomatosis: An Augmented Risk for Premature Cardiovascular Disease.” Atherosclerosis (00219150), vol. 355, Aug. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2022.06.632.
APA
Cohen, H., & Hassin-Baer, S. (2022). Features of the metabolic syndrome and subclinical atherosclerosis in patients with cerebrotendinous xanthomatosis: An augmented risk for premature cardiovascular disease. Atherosclerosis (00219150), 355, N.PAG. https://doi.org/10.1016/j.atherosclerosis.2022.06.632
Chicago
Cohen, H., and S. Hassin-Baer. 2022. “Features of the Metabolic Syndrome and Subclinical Atherosclerosis in Patients with Cerebrotendinous Xanthomatosis: An Augmented Risk for Premature Cardiovascular Disease.” Atherosclerosis (00219150) 355 (August): N.PAG. doi:10.1016/j.atherosclerosis.2022.06.632.